Dr. Gregory Friedman, MD
Claim this profileChildren's Hospital of Alabama
Studies Relapse
Studies Cancer
21 reported clinical trials
33 drugs studied
Area of expertise
1Relapse
Stage IV
NF1 positive
Stage I
2Cancer
Stage IV
NTRK1 positive
NTRK positive
Affiliated Hospitals
Clinical Trials Gregory Friedman, MD is currently running
CBL0137
for Cancer
This trial tests CBL0137, a drug that blocks signals inside cancer cells, in patients whose solid tumors, including CNS tumors or lymphoma, have returned or not responded to treatment. By interfering with the cells' internal communication, the drug aims to stop their growth and cause them to die. CBL0137, also known as Curaxin, has shown antitumor activity in multiple cancers, including glioblastoma, renal cell carcinoma, melanoma, neuroblastoma, and small cell lung cancer.
Recruiting1 award Phase 1 & 213 criteria
Abemaciclib + Temozolomide
for Brain Tumors
The purpose of this study is to measure the benefit of adding abemaciclib to the chemotherapy, temozolomide, for newly diagnosed high-grade glioma following radiotherapy. Your participation could last approximately 11 months and possibly longer depending upon how you and your tumor respond.
Recruiting1 award Phase 26 criteria
More about Gregory Friedman, MD
Clinical Trial Related1 year of experience running clinical trials · Led 21 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Gregory Friedman, MD has experience with
- Ramucirumab
- G207
- Nivolumab
- Docetaxel
- Gemcitabine
- Cyclophosphamide
Breakdown of trials Gregory Friedman, MD has run
Relapse
Cancer
Brain Tumor
Brain Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gregory Friedman, MD specialize in?
Gregory Friedman, MD focuses on Relapse and Cancer. In particular, much of their work with Relapse has involved Stage IV patients, or patients who are NF1 positive.
Is Gregory Friedman, MD currently recruiting for clinical trials?
Yes, Gregory Friedman, MD is currently recruiting for 9 clinical trials in Birmingham Alabama. If you're interested in participating, you should apply.
Are there any treatments that Gregory Friedman, MD has studied deeply?
Yes, Gregory Friedman, MD has studied treatments such as Ramucirumab, G207, Nivolumab.
What is the best way to schedule an appointment with Gregory Friedman, MD?
Apply for one of the trials that Gregory Friedman, MD is conducting.
What is the office address of Gregory Friedman, MD?
The office of Gregory Friedman, MD is located at: Children's Hospital of Alabama, Birmingham, Alabama 35233 United States. This is the address for their practice at the Children's Hospital of Alabama.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.